CD8A and neoplasm: To determine whether the transfer of CD4+ and CD8+ T cells was responsible for the augmentation of antitumor immunity in this model system, irradiated lymphopenic mice were reconstituted with ex vivo—expanded CD4+ T cells or CD8+ T cells and then challenged with MCA205 tumor cells.